Results 131 to 140 of about 33,100 (246)

Mycochemical Diversity and Therapeutic Potential of Hymenochaetoid Fungi from Central Asia: Regional and Global Perspectives

New Zealand Journal of Botany, Volume 64, Issue 1, March 2026.
Central Asia harbors a rich yet understudied assemblage of wood‐inhabiting Hymenochaetoid fungi. This review delivers the first comprehensive synthesis of 43 poroid species representing 18 genera documented across montane forests, steppes, and xeric habitats.
Yusufjon Gafforov, Milena Rašeta, Sylvie Rapior, Manzura Yarasheva, Oksana Mykchaylova, Rustamjon Allaberdiev, Şule İnci, Dilfuza Berdieva, Arshad Mehmood Abbasi, Shikhnazar Khodjaev, Dian‐Ming Hu, Weijun Yang, Abudujilili Abuduaini, Maria Letizia Taddei, Mengcen Wang, Islomjon Urinboev, Jiajia Chen   +16 more
wiley   +1 more source

Liver Transplantation for Hepatocarcinoma: Results over Two Decades of a Transplantation Programme and Analysis of Factors Associated with Recurrence

Biomedicines
Background: In recent years, many studies have attempted to develop models to predict the recurrence of hepatocarcinoma after liver transplantation.
María Martínez Burgos, Rocío González Grande, Susana López Ortega, Inmaculada Santaella Leiva, Jesús de la Cruz Lombardo, Julio Santoyo Santoyo, Miguel Jiménez Pérez   +6 more
doaj   +1 more source

Hepatocarcinoma

, 2014
Introdução: O Hepatocarcinoma é um dos cancros mais comuns no mundo atingindo 600.000 indivíduos por ano. É causado, principalmente, pela infeção pelo vírus da hepatite B e C seguido pelo alcoolismo crónico, infeção por aflotoxina e esteato-hepatite não alcoólica.
openaire   +1 more source

Combined hepatocarcinoma-cholangiocarcinoma in patients treated as hepatocarcinoma [PDF]

HPB, 2018
L.A. Martinez Insfran, B. Gomez Perez, P. Ramirez Romero, L. Barona, G. Carbonell, F. Alconchel Gago, P. Cascales Campos, F. Sanchez Bueno, R. Robles Campos, P. Parrilla Paricio   +9 more
openaire   +1 more source

Protein tyrosine phosphatases as emerging targets for cancer immunotherapy

British Journal of Pharmacology, Volume 183, Issue 6, Page 1233-1249, March 2026.
Abstract Contemporary strategies in cancer immunotherapy, despite remarkable success, remain constrained by inherent limitations such as suboptimal patient responses, the emergence of drug resistance, and the manifestation of pronounced adverse effects. Consequently, the need for alternative strategies for immunotherapy becomes clear.
Zihan Qu, Jiajun Dong, Zhong‐Yin Zhang
wiley   +1 more source

MASLD-related HCC: Multicenter study comparing patients with and without cirrhosis

JHEP Reports
Background & Aims: Despite its growing incidence, hepatocellular carcinoma (HCC) related to metabolic dysfunction-associated steatotic liver disease (MASLD) in non-cirrhotic livers remains poorly characterized.
Carole Vitellius, Elvire Desjonqueres, Marie Lequoy, Giuliana Amaddeo, Isabelle Fouchard, Gisele N’Kontchou, Clemence M. Canivet, Marianne Ziol, Hélène Regnault, Adrien Lannes, Frederic Oberti, Jerome Boursier, Nathalie Ganne-Carrie   +12 more
doaj   +1 more source

Resultados a corto y largo plazo del tratamiento quirúrgico del hepatocarcinoma [PDF]

, 2016
El hepatocarcinoma (HCC) es una causa importante de mortalidad en pacientes con cirrosis. El tratamiento quirúrgico es de elección en pacientes seleccionados con buena función hepática y una alternativa sólida frente al trasplante.
Martínez Casals, Ana, Zuñiga-Villacrecis Viza, Estefani   +1 more
core  

Metformin Impairs Breast Cancer Growth through the Inhibition of PRMT6

Advanced Science, Volume 13, Issue 8, 9 February 2026.
Metformin has a biological activity against breast cancer. However, it is largely unknown about its precise therapeutic targets. Here, histone arginine methyltransferase PRMT6 is identified as a new anti‐cancer target for metformin. Metformin directly binds PRMT6 and inhibits its ability to catalyze histone H3R2 asymmetric dimethylation (H3R2me2a ...
Yinsheng Wu, Xinlin Xu, Yue Tong, Min Wang, Feng Ge, Min Wu, Yunlong Wang, Gang Chen, Xilan Yu, Shanshan Li   +9 more
wiley   +1 more source

Termoablación en el hepatocarcinoma

, 2020
Grado en ...
openaire   +2 more sources

Statins in Breast Cancer Therapy: Mechanistic Insights and Emerging Evidence

Cancer Innovation, Volume 5, Issue 1, February 2026.
Statins, particularly simvastatin, demonstrate potential as adjuvant agents in breast cancer treatment by disrupting tumour cell signalling and survival pathways. This review highlights emerging evidence supporting their repurposing for improved outcomes, especially in aggressive breast cancer subtypes.
Rohina Alim, H. M. Kasuni Akalanka
wiley   +1 more source